SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thomas W. Concannon, Jeanne-Marie Guise, Rowena J. Dolor, Paul Meissner, Sean Tunis, Jerry A. Krishnan, Wilson D. Pace, Joel Saltz, William R. Hersh, Lloyd Michener, Timothy S. Carey, A National Strategy to Develop Pragmatic Clinical Trials Infrastructure, Clinical and Translational Science, 2014, 7, 2
  2. 2
    Kevin Mullane, Raymond J. Winquist, Michael Williams, Translational paradigms in pharmacology and drug discovery, Biochemical Pharmacology, 2014, 87, 1, 189

    CrossRef

  3. 3
    Robin C. Vanderpool, Ross C. Brownson, Glen P. Mays, Richard A. Crosby, Stephen W. Wyatt, A Partnership of Two U.S. Research Networks to Improve Public Health, American Journal of Preventive Medicine, 2013, 45, 6, 745

    CrossRef

  4. 4
    Janneke P. C. Grutters, Mark Sculpher, Andrew H. Briggs, Johan L. Severens, Math J. Candel, James E. Stahl, Dirk De Ruysscher, Albert Boer, Bram L. T. Ramaekers, Manuela A. Joore, Acknowledging Patient Heterogeneity in Economic Evaluation, PharmacoEconomics, 2013, 31, 2, 111

    CrossRef

  5. 5
    Stefanie Joos, Jutta Bleidorn, Jörg Haasenritter, Eva Hummers-Pradier, Frank Peters-Klimm, Ildikó Gágyor, Ein Leitfaden zur Planung Nichtmedikamentöser klinischer Studien in der Primärversorgung unter Berücksichtigung der Kriterien der Guten Klinischen Praxis (GCP), Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2013, 107, 1, 87

    CrossRef

  6. 6
    K. M. McDonald, C. L. Bryce, M. L. Graber, The patient is in: patient involvement strategies for diagnostic error mitigation, BMJ Quality & Safety, 2013, 22, Suppl 2, ii33

    CrossRef

  7. 7
    Katrina A.B. Goddard, William A. Knaus, Evelyn Whitlock, Gary H. Lyman, Heather Spencer Feigelson, Sheri D. Schully, Scott Ramsey, Sean Tunis, Andrew N. Freedman, Muin J. Khoury, David L. Veenstra, Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research, Genetics in Medicine, 2012, 14, 7, 633

    CrossRef

  8. 8
    Judith van Loon, Janneke Grutters, Fergus Macbeth, Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?, The Lancet Oncology, 2012, 13, 4, e169

    CrossRef

  9. 9
    Kenneth G. Saag, Penny E. Mohr, Laura Esmail, Amy S. Mudano, Nicole Wright, Timothy Beukelman, Jeffrey R. Curtis, Gary Cutter, Elizabeth Delzell, Lisa C. Gary, T. Michael Harrington, Swapna Karkare, Meredith L. Kilgore, Cora Elizabeth Lewis, Rachael Moloney, Ana Oliveira, Jasvinder A. Singh, Amy Warriner, Jie Zhang, Marc Berger, Steven R. Cummings, Wilson Pace, Daniel H. Solomon, Robert Wallace, Sean R. Tunis, Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States, Contemporary Clinical Trials, 2012, 33, 6, 1211

    CrossRef

  10. 10
    Jean-Pierre Lehner, Robert S Epstein, Tehseen Salimi, Integrating new approaches for clinical development: translational research and relative effectiveness, Journal of Comparative Effectiveness Research, 2012, 1, 1s, 15

    CrossRef

  11. 11
    Hans-Christian Deter, Psychosocial interventions for patients with chronic disease, BioPsychoSocial Medicine, 2012, 6, 1, 2

    CrossRef

  12. 12
    Daniel M Hartung, Jeanne-Marie Guise, Lyle J Fagnan, Melinda M Davis, Kurt C Stange, Role of practice-based research networks in comparative effectiveness research, Journal of Comparative Effectiveness Research, 2012, 1, 1, 45

    CrossRef

  13. 13
    Danielle C Lavallee, Carla J Williams, Ellen S Tambor, Patricia A Deverka, Stakeholder engagement in comparative effectiveness research: how will we measure success?, Journal of Comparative Effectiveness Research, 2012, 1, 5, 397

    CrossRef

  14. 14
    Kevin Mullane, Michael Williams, Translational semantics and infrastructure: another search for the emperor's new clothes?, Drug Discovery Today, 2012, 17, 9-10, 459

    CrossRef